
Détail de l'auteur
Auteur M. PAZITNY |
Documents disponibles écrits par cet auteur (3)

![]()
Article : Périodique
V. BELACKOVA ; M. PAZITNY ; E. DRAPALOVA ; M. MARTINEZ ; D. VAN DER GOUWE ; E. BEGLEY ; M. KIDAWA ; A. TOMKOVA ; D. KMETONYNOVA |Aims: The indicator of availability has been used in the risk assessment (RA) of new psychoactive substances (NPS). This paper aims to examine the pre- and post-control availability of 25I-NBOMe, AH-7921, MDPV and MXE, which were assessed by the[...]Nouveauté
![]()
Article : Périodique
V. BELACKOVA ; M. PAZITNY ; E. DRAPALOVA ; M. MARTINEZ ; D. VAN DER GOUWE ; E. BEGLEY ; M. KIDAWA ; A. TOMKOVA ; D. KMETONYNOVA |Aims: The indicator of availability has been used in the risk assessment (RA) of new psychoactive substances (NPS). This paper aims to examine the pre- and post-control availability of 25I-NBOMe, AH-7921, MDPV and MXE, which were assessed by the[...]![]()
Article : Périodique
T. M. BRUNT ; A. M. ATKINSON ; T. NÉFAU ; M. MARTINEZ ; E. LAHAIE ; A. MALZCEWSKI ; M. PAZITNY ; V. BELACKOVA ; S. D. BRANDT |Background: New psychoactive substances (NPS) are on offer worldwide online, in order to shed light on the purity and price of these substances in the European Union, a research collaboration was set up involving France, United Kingdom (UK), the[...]Nouveauté